Anya Katherine Nelson

Ms. Anya Katherine Nelson

Northumbria University, Newcastle upon Tyne, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2022 in Molecules
Verified
Journal Article
Open access
PDF file
JBJoseph C. J. Bergin
Joseph C. J. Bergin
KTKean Kan Tan
Kean Kan Tan
ANAnya Katherine Nelson
Anya Katherine Nelson
CACristina-Andreea Amarandei
Cristina-Andreea Amarandei
VHVéronique Hubscher-Bruder
Véronique Hubscher-Bruder
DTDavid Tetard
David Tetard
Two analogues of tolcapone where the nitrocatechol group has been replaced by a 1-hydroxy-2(1H)-pyridinone have been designed and synthesised. These compounds are expected to have a dual mode of action both beneficial against Parkinson’s disease: they are designed to be inhibitors of catechol O-methyl transferase, which contribute to the reduction of dopamine in the brain, and to protect neurons against oxidative damage. To assess whether these compounds are worthy of biological assessment to demonstrate these effects, measurement of their pKa and stability constants for Fe(III), in silico modelling of their potential to inhibit COMT and blood–brain barrier scoring were performed. These results demonstrate that the compounds may indeed have the desired properties, indicating they are indeed promising candidates for further evaluation.